# ReEngage Therapeutics, Inc. — Form D/A

ReEngage Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2025-07-01. The offering totals $8.0M, of which $365K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-07-01
- Form: D/A
- Accession: 0002022524-25-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $365K
- Remaining: $7.6M
- Investors: 6
- Date of first sale: 2025-06-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-549288

## Issuer

- Name: ReEngage Therapeutics, Inc.
- CIK: 0002022524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2450 HOLCOMBE BLVD. SUITE 1200, HOUSTON, TX, 77021
- Phone: 215-400-0133

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Kim | Director | Houston, TX |
| Thomas Kim | Executive Officer | Houston, TX |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-06-18](https://search.stillhousedata.com/formd/0002022524-25-000002) | D | $8.0M | $250K |
| [2024-12-16](https://search.stillhousedata.com/formd/0002022524-24-000002) | D | $3.0M | $65K |

## More

- [CIK 2022524 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022524&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002022524-25-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.